Home›Companies›Healthcare›Akura Medical

Akura Medical, Inc.

Updated Oct 27, 2026·Latest SEC filing Dec 3, 2025·Suggest an edit

About Akura Medical

Akura Medical is a private company based in Campbell, California. It has reported $94,835,451 raised in three offerings on Form D since January 2022. Its chief executive is Amr Salahieh.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Nov 12, 2025Dec 3, 2025$51,449,999of $71.9M target20$2.5MEquityRule 506(b)Form D ↗
Sep 26, 2023Oct 6, 2023$18,385,452of $35.0M target27$680KEquityRule 506(b)Form D ↗
Dec 21, 2021Jan 5, 2022$25,000,000fully sold59$423KEquityRule 506(b)Form D ↗
Total, three offerings$94,835,451

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Akura Medical's Form D filed Dec 3, 2025.

MM
Mariam Maghribi
Director
Also an executive officer at Laza Medical and Supira Medical and a president and chief executive officer, director at Tioga Cardiovascular.
GK
Gautam Kainth
Director
Also a director at Adona Medical and Tioga Cardiovascular.
AS
Amr Salahieh
Chief Executive Officer and director
Also a director at Adona Medical and Supira Medical and a chief executive officer and director at Laza Medical.

Earlier filings also listed Murali Srivathsa (chief executive officer, last listed Oct 2023) and David Voris (executive officer, last listed Oct 2023).

Sources

  1. SECAkura Medical, Inc. filing history